Delivery Order SPE2DB20D3103-SPE2DB23FN6L4
Award Date
6/7/23
Potential Completion Date
6/8/23
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.80 firm fixed price delivery order is for the supply of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $86,876.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of NALOXONE 10ML 25S, a critical medication used in the treatment of opioid overdose. The contract has an ultimate completion date of December 28, 2015 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,946.41, is for the provision of 2 mg/2 ml naloxone syringes. The contract is a firm fixed-price Delivery Order with no set-aside designation, meaning it was open to full and open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,255.77 firm fixed-price delivery order is for the supply of 4,567,473,255 units of 2 mg/2 ml naloxone syringes. The award has an ultimate completion date of March 6, 2025 and was issued on March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of naloxone, a medication used to reverse opioid overdose. The award, valued at $2,480.47, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,527.15, is for the delivery of Naloxone 2 mg/2 ml syringes to an unspecified location. It is a firm fixed-price delivery order contract with the Defense Logistics Agency (DLA) Troop Support Medical under the agency's primary Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued up...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.00, is for the delivery of NALOXONE 0.4 MG/ML VIALML, a critical pharmaceutical product. This is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,213.48, is for the delivery of 4,567,754,528 units of 2 mg/2 mL naloxone syringes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,486.94, is a delivery order for the procurement of Naloxone 0.4 mg/ml vials. Naloxone is a medication used to reverse opioid overdose. The contract is a firm fixed-price, with an ultimate completion date of November 21, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.19 firm fixed-price delivery order is for the supply of naloxone 2 mg/2 ml syringes. The contract has an ultimate completion date of March 11, 2024 and was awarded on March 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...